Skip to main content
. 2019 Oct 1;9:14082. doi: 10.1038/s41598-019-50683-2

Table 1.

Hematologic data and liver function test of Swiss mice immunized with nano-iCnB.

Parameters Nano-milliQW Non-immunized-control Nano-iCnB Non-immunized-challenged Reference
Total Leukocytes, (mm3) 9600 (864)ns 8466 (982) 11733 (499) 12933 (7128) 4300–10000, (mm3)
Hemoglobin, (g/dL) 14,73 (0,51)ns 10,60 (2,80) 16,17 (0,51) 20,73 (1,80)* 13–17, (g/dL)
Hematocrit, (%) 44,33 (1,53)ns 38,80 (4,50) 48,67 (1,53) 64,67 (3,05)* 39–51, (%)
Alanine Transaminase (ALT), (U/L) 38 (12)ns 32 (12) 31 (11) 211 (73)* 26–60, (U/L)
Aspartate aminotransferase (AST), (U/L) 130 (65)ns 156 (38) 180 (49) 414 (72)* 81–184, (U/L)
Alkaline phosphatase (AP), (U/L) 125 (74)ns 183 (7,20) 190 (6) 206 (28) 63–196, (U/L)

Non-immunized-control (healthy animals); nano-milliQW; nano-iCnB; Non-Immunized-challenged with 157 LD50.g−1. ns – not significant - sera from Swiss mice non-immunized-control vs sera from Swiss mice inoculated with nano-milliQW. *significant - hemoglobin (p < 0.05); hematocrit (p < 0.05); ALT (p < 0.04); AST (p < 0.01) sera from immunized Swiss mice vs Non-immunized-challenged.